Association between dysglycemia and the Charlson Comorbidity Index among hospitalized patients with diabetes
Related Experiment Video
Updated: Aug 28, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Sara Atiq Khan1, Stephen Shields1, Mohammed S Abusamaan1
1Division of Endocrinology, Diabetes, & Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Insights
Inpatient hyperglycemia and hypoglycemia increase one-year mortality risk in diabetes patients. Hypoglycemia showed a stronger association, suggesting diabetes complications may mediate this increased mortality risk.
Area of Science:
- Endocrinology
- Internal Medicine
- Public Health
Background:
- Inpatient dysglycemia (abnormal blood glucose) is linked to short-term mortality.
- Longer-term mortality data for inpatient dysglycemia remain limited.
Purpose of the Study:
- To investigate the association between inpatient dysglycemia and one-year mortality risk in adults with diabetes.
Main Methods:
- Retrospective chart review of 22,639 adult diabetes admissions (2015-2019).
- Charlson Comorbidity Index (CCI) used to stratify mortality risk (low: ≤5, high: ≥6).
- Logistic regression analyzed associations between dysglycemic measures and high mortality risk.
Main Results:
- Hyperglycemia (BG ≥180 mg/dL, ≥300 mg/dL) and hypoglycemia (BG ≤70 mg/dL, <54 mg/dL, <40 mg/dL) were associated with increased one-year mortality risk.
- Hypoglycemia demonstrated a stronger association with mortality than hyperglycemia.
- Older age and Black race were linked to both hyperglycemia and hypoglycemia.
Conclusions:
- Both inpatient hypoglycemia and hyperglycemia are positively associated with increased one-year mortality.
- The association between dysglycemia and mortality appears to be primarily mediated by diabetes-related complications.
Aim:
Inpatient dysglycemia has been linked to short-term mortality, but longer-term mortality data are lacking. Our aim was to evaluate the association between inpatient dysglycemia and one-year mortality risk.
Methods:
Retrospective chart review of adults with diabetes hospitalized between 2015 and 2019. The Charlson Comorbidity Index (CCI) was used to estimate 1-year mortality risk, stratified into low (CCI ≤ 5) and high risk (CCI ≥6). Simple and multivariable logistic regression was used to evaluate the association between dysglycemic measures and high mortality risk.
Results:
Among 22,639 unique admissions, BG ≥ 180, ≥300, ≤70, <54 and <40 mg/dL were associated with adjusted odds of 1.43 (95 % CI, 1.33, 1.54), 1.58 (95 % CI, 1.48, 1.68), 2.16 (95 % CI, 2.01, 2.32), 2.58 (95 % CI, 2.32, 2.86), and 2.56 (95 % CI, 2.19, 2.99) for high mortality risk, respectively. Older age and Black race were positively associated with hyperglycemia and hypoglycemia. Myocardial infarction, congestive heart failure (CHF), and moderate to severe liver disease were most strongly associated with hyperglycemia, while renal disease, CHF, peripheral vascular disease, and peptic ulcer disease were most strongly associated with hypoglycemia.
Conclusions:
Inpatient hypoglycemia and hyperglycemia were both positively associated with higher one-year mortality risk, with stronger magnitude of association observed for hypoglycemia. The association appears to be mediated mainly by presence of diabetes-related complications.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Hypoglycemia and Glucagon
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...